Table 1 Baseline and biochemical characteristics in patients
Variable | HDL-C/apoA-I ( mmol/g) | |||||||
|---|---|---|---|---|---|---|---|---|
Total (n = 1686) | T1 (0.190–0.836) | T2 (0.837–0.947) | T3 (0.948–5.500) | P | P1 | P2 | P3 | |
(n = 563) | (n = 558) | (n = 565) | ||||||
Age, years | 58.0 (66.0–72.0) | 64.0 (56.0–71.0) | 66.0 (59.0–72.0) | 68.0 (60.0–73.5) | < 0.001 | 0.020 | < 0.001 | 0.023 |
Male [n (%)] | 1115 (66.1) | 384 (68.2) | 352 (63.0) | 379 (67.0) | 0.163 | |||
BMI (kg/m2) | 24.6 (22.5–26.9) | 25.3 (23.4–27.4) | 24.7 (22.8–26.0) | 23.4 (21.5–25.7) | < 0.001 | 0.010 | < 0.001 | < 0.001 |
PP (mm/Hg) | 55.0 (45.0–66.0) | 55.0 (47.0–65.0) | 55.0 (46.0–68.0) | 54.0 (44.0–64.0) | 0.027 | 1.000 | 0.157 | 0.030 |
BUN/CR (g/mmol) | 0.78 (0.65–0.95) | 0.08 (0.06–0.95) | 0.08 (0.07–0.96) | 0.08 (0.06–0.94) | 0.156 | |||
TGs (mmol/L) | 1.50 (1.08–2.11) | 2.05 (1.48–3.09) | 1.53 (1.17–2.00) | 1.11 (0.86–1.46) | < 0.001 | < 0.001 | < 0.001 | < 0.001 |
LDL-C (mmol/L) | 2.63 (2.05–3.29)) | 2.52 (2.02–3.09) | 2.85 (2.21–3.45) | 2.62 (1.97–3.39) | < 0.001 | < 0.001 | 0.046 | 0.024 |
ApoB (g/L) | 0.84 (0.67–1.04) | 0.85 (0.70–1.11) | 0.88 (0.70–1.04) | 0.78 (0.62–0.95) | < 0.001 | 1.000 | < 0.001 | < 0.001 |
FT3 (pmol/L) | 4.51 (4.06–5.02) | 4.73 (4.29–5.20) | 4.46 (4.05–4.95) | 4.36 (3.84–4.86) | < 0.001 | < 0.001 | < 0.001 | 0.025 |
FT4 ( pmol/L) | 16.85 (15.06–18.79) | 16.98 (14.99–18.73) | 16.52 (14.98–18.40) | 16.97 (15.26–19.11) | 0.065 | |||
TSH (mIU/L) | 1.85 (1.18–2.96) | 2.02 (1.24–3.17) | 1.94 (1.27–3.00) | 1.69 (1.08–2.65) | < 0.001 | 1.000 | < 0.001 | 0.001 |
DM, n (%) | 1279 (75.8) | 179 (32.0) | 144 (25.0) | 105 (19.0) | < 0.001 | 0.049 | < 0.001 | 0.018 |
EH, n (%) | 1170 (69.3) | 421 (74.0) | 384 (69.0) | 365 (64.0) | 0.001 | 0.090 | 0.001 | 0.406 |
CAD, n (%) | 1279 (75.8) | 448 (79.0) | 426 (76.0) | 405 (71.0) | 0.008 | 0.620 | 0.204 | 0.006 |